Iovance Biotherapeutics, Inc.
2018 Q3 - 2025 Q4 (23 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/12/2026 | 466 | 0.0% | 170,782 | 12/31/2025 |
| 2025 Q3 | 11/13/2025 | 307 | 0.0% | 141,686 | 9/30/2025 |
| 2025 Q2 | 8/13/2025 | 260 | 0.0% | 150,974 | 6/30/2025 |
| 2025 Q1 | 5/14/2025 | 504 | 0.0% | 151,206 | 3/31/2025 |
| 2024 Q4 | 2/13/2025 | 1,227 | 0.0% | 165,842 | 12/31/2024 |
| 2024 Q3 | 11/13/2024 | 1,375 | 0.0% | 146,416 | 9/30/2024 |
| 2024 Q2 | 8/13/2024 | 1,174 | 0.0% | 146,416 | 6/30/2024 |
| 2024 Q1 | 5/14/2024 | 1,795 | 0.0% | 121,106 | 3/31/2024 |
| 2023 Q4 | 4/22/2024 | 985 | 0.0% | 121,106 | 12/31/2023 |
| 2023 Q3 | 5/9/2024 | 551 | 0.0% | 121,106 | 9/30/2023 |
| 2023 Q2 | 4/29/2024 | 772 | 0.0% | 109,716 | 6/30/2023 |
| 2023 Q1 | 5/9/2024 | 480 | 0.0% | 78,571 | 3/31/2023 |
| 2022 Q4 | 5/10/2024 | 502 | 0.0% | 78,571 | 12/31/2022 |
| 2022 Q3 | 5/10/2024 | 753 | 0.0% | 78,571 | 9/30/2022 |
| 2022 Q2 | 5/10/2024 | 867 | 0.0% | 78,571 | 6/30/2022 |
| 2022 Q1 | 5/10/2024 | 83 | 0.0% | 5,005 | 3/31/2022 |
| 2020 Q1 | 7/12/2023 | 1,471 | 0.0% | 49,133 | 3/31/2020 |
| 2019 Q4 | 7/12/2023 | 1,428 | 0.0% | 51,593 | 12/31/2019 |
| 2019 Q3 | 7/12/2023 | 939 | 0.0% | 51,593 | 9/30/2019 |
| 2019 Q2 | 7/12/2023 | 1,185 | 0.0% | 48,312 | 6/30/2019 |
| 2019 Q1 | 7/13/2023 | 459 | 0.0% | 48,312 | 3/31/2019 |
| 2018 Q4 | 7/13/2023 | 428 | 0.0% | 48,312 | 12/31/2018 |
| 2018 Q3 | 7/13/2023 | 436 | 0.0% | 38,763 | 9/30/2018 |